Document is current
Any future updates will be listed below
-
Authors
Kolk, Maarten Z. H.
Ruipérez-Campillo, Samuel
Allaart, Cornelis P.
Wilde, Arthur A. M.
Knops, Reinoud E.
Narayan, Sanjiv M.
Tjong, Fleur V. Y.
,
Raijmakers, Femke D.
Van Der Lingen, Anne-Lotte C. J.
Götte, Marco J. W.
Selder, Jasper L.
Alvarez-Florez, Laura
Išgum, Ivana
Bekkers, Erik J.
-
Funding
Funding for this research was provided by:
Dutch Research Council (452019308)
- License Information
-
More Information
Article History
Received: 28 February 2024
Accepted: 19 June 2024
First Online: 27 June 2024
Competing interests
: S.M.N. reports grant or contracts from National Institutes of Health (NIH), consulting fees from Abbott Inc. and royalties and licenses from Uptodate. R.E.K. reports consultancy fees and research grants from Boston Scientific, Medtronic and Abbott Inc. and has stock options from AtaCor Medical Inc. F.V.Y.T. has grants or contracts from the Dutch Research Council (NWO) and Amsterdam Cardiovascular Sciences, and received honoraria fees from Boston Scientific and Abbott Inc (no personal financial gain). A.A.W. is consultant for ARMGO and Thyrv Therapeutics (unpaid), and participates on a Data Safety Monitoring Board for the LEAP trial. C.P.A. reports grants or contracts from Biotronik. M.Z.H.K., S.R.C have nothing to declare.
